Development of lipid nanoparticles mRNA vaccine against viral Influenza infection

Manufacture and immunogenicity of therapeutic RNA Hepatitis C Virus genotype 4 vaccine by bio-informatics

Development of Lipid Nanoparticles [LNP]-RNA Vaccine Against Neisseria Meningitidis CPS Gene Locus Facilitating the Synthesis of The Capsular Polysaccharide in Egypt

Development and characterization of nanostructure lipid carrier for anti-hepatitis-C virus drug

The exploitation of Hepatitis C virus-like particles vaccine against genotype 4 by bioinformatics

Design of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer m

Pattern of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer

Development of lipid nanoparticles(LNP)- RNA vaccine against <i>Streptococcus pneumoniae</i> gene cluster facilitating the synthesis of the capsular polysaccharide in Egypt.

ADVANCED TRENDS FOR PRODUCTION OF HEPATITIS B VIRUS SUBVIRAL PARTICLES USING DIFFERENT TECHNIQUE TO ENHANCE OVERCOME OF HEPATITIS B VIRUS INFECTION

Respiratory Syncytial Virus Vaccine mRNA Lipid Nanoparticles Pattern Determined Via Bioinformatics